Phytochemicals for mitigating the COVID-19 crisis: evidence from pre-clinical and clinical studies
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in December 2019 quickly escalated to pandemic levels and had a severe impact on public health. There are 761 million confirmed coronavirus disease 2019 (COVID-19) cases, with over 6.88 million deaths worldwide ti...
Saved in:
Main Authors: | Atri Das, Swarnali Khan, Syamal Roy, Shantanabha Das |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration
2023-10-01
|
Series: | Exploration of Drug Science |
Subjects: | |
Online Access: | https://www.explorationpub.com/uploads/Article/A100824/100824.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Traits of SARS-CoV-2 Infection
by: O. Yu. Zolnikova, et al.
Published: (2020-12-01) -
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 20201
by: Andrew, Baguma, et al.
Published: (2021) -
Respiratory pathogen spectrum and epidemiological trends in Hainan Province: a retrospective analysis from 2017 to 2023
by: Lvying Wu, et al.
Published: (2025-02-01) -
Role of phytochemicals in cardiovascular disease management: Insights into mechanisms, efficacy, and clinical application
by: Esther Ugo Alum
Published: (2025-02-01) -
An Overview on The Pandemic Coronavirus Disease 2019 (COVID-19) Outbreak
by: Mariwan Abdulla Hama Salih
Published: (2020-05-01)